ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,295,603 | -4.5% | 6,280,813 | +3.8% | 0.44% | +18.2% |
| Q2 2023 | $9,737,478 | -40.2% | 6,048,123 | +7.8% | 0.37% | -47.0% |
| Q1 2023 | $16,274,962 | -20.5% | 5,612,056 | -10.1% | 0.71% | -15.8% |
| Q4 2022 | $20,476,240 | -13.2% | 6,242,756 | 0.0% | 0.84% | -8.4% |
| Q3 2022 | $23,598,000 | -51.5% | 6,242,756 | 0.0% | 0.92% | -50.7% |
| Q2 2022 | $48,631,000 | -16.2% | 6,242,756 | -0.1% | 1.86% | +2.5% |
| Q1 2022 | $58,025,000 | -42.8% | 6,245,911 | -3.0% | 1.81% | -21.5% |
| Q4 2021 | $101,459,000 | -12.3% | 6,437,777 | -0.4% | 2.31% | +14.3% |
| Q3 2021 | $115,746,000 | +15.4% | 6,466,277 | +0.3% | 2.02% | +36.1% |
| Q2 2021 | $100,291,000 | +1.4% | 6,449,577 | -6.3% | 1.48% | +6.5% |
| Q1 2021 | $98,872,000 | -26.6% | 6,885,233 | +0.3% | 1.39% | -14.6% |
| Q4 2020 | $134,722,000 | +49.8% | 6,863,070 | -1.1% | 1.63% | -1.2% |
| Q3 2020 | $89,928,000 | -9.8% | 6,938,870 | +1.4% | 1.65% | -10.3% |
| Q2 2020 | $99,708,000 | +121.3% | 6,843,370 | +29.3% | 1.84% | +45.8% |
| Q1 2020 | $45,047,000 | -41.2% | 5,293,370 | +13.9% | 1.26% | -31.0% |
| Q4 2019 | $76,562,000 | +20.0% | 4,648,570 | +2.9% | 1.83% | -14.3% |
| Q3 2019 | $63,818,000 | -31.0% | 4,519,717 | -1.8% | 2.14% | -18.4% |
| Q2 2019 | $92,524,000 | -48.1% | 4,600,917 | +2.6% | 2.62% | -49.8% |
| Q1 2019 | $178,295,000 | +16.3% | 4,485,417 | +1.6% | 5.22% | -15.4% |
| Q4 2018 | $153,364,000 | -12.1% | 4,414,617 | +4.6% | 6.17% | +14.9% |
| Q3 2018 | $174,444,000 | +15.0% | 4,218,717 | +2.2% | 5.37% | +4.2% |
| Q2 2018 | $151,653,000 | -8.2% | 4,126,617 | -2.6% | 5.15% | -19.2% |
| Q1 2018 | $165,205,000 | +224.1% | 4,236,017 | +50.4% | 6.38% | +187.9% |
| Q4 2017 | $50,969,000 | +6.6% | 2,815,988 | -2.6% | 2.22% | -6.1% |
| Q3 2017 | $47,825,000 | +24.9% | 2,889,710 | +5.7% | 2.36% | +1.2% |
| Q2 2017 | $38,277,000 | -31.9% | 2,734,044 | -0.0% | 2.33% | -36.1% |
| Q1 2017 | $56,186,000 | +48.1% | 2,734,118 | +2.4% | 3.65% | +11.6% |
| Q4 2016 | $37,927,000 | -12.3% | 2,670,942 | +32.1% | 3.27% | -4.9% |
| Q3 2016 | $43,242,000 | -20.3% | 2,021,617 | -16.1% | 3.44% | -33.6% |
| Q2 2016 | $54,226,000 | +25.2% | 2,408,970 | +5.9% | 5.18% | +16.9% |
| Q1 2016 | $43,308,000 | +6.8% | 2,275,765 | +48.3% | 4.43% | +46.1% |
| Q4 2015 | $40,538,000 | +22.8% | 1,534,962 | +46.2% | 3.03% | +21.3% |
| Q3 2015 | $33,005,000 | +67.9% | 1,049,782 | +181.7% | 2.50% | +55.2% |
| Q2 2015 | $19,661,000 | +78.3% | 372,642 | +40.5% | 1.61% | +62.7% |
| Q1 2015 | $11,025,000 | +56.0% | 265,205 | +0.4% | 0.99% | +28.6% |
| Q4 2014 | $7,069,000 | – | 264,266 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |